WWP2 regulates pathological cardiac fibrosis by modulating SMAD2 signaling

Journal: Nature Communications

Published: 2019-08-09

DOI: 10.1038/s41467-019-11551-9

Affiliations: 21

Authors: 27

Go to article
Institutions Share
Duke-NUS Cardiovascular and Metabolic Disorders (CVMD), Singapore 0.27
National Heart and Lung Institute (NHLI), ICL, United Kingdom (UK) 0.15
Division of Brain Sciences, ICL, United Kingdom (UK) 0.07
National Heart Centre Singapore (NHCS), Singapore 0.07
MRC London Institute of Medical Sciences (LMS), United Kingdom (UK) 0.07
Cardiovascular Research Centre (CRC), Royal Brompton and Harefield NHS Foundation Trust, United Kingdom (UK) 0.06
Human Evolutionary Genetics Unit (GEMS), France 0.04
Ospedale Civile San Giovanni di Dio, Italy 0.04
Department of Emergency and Organ Transplants (DETO), UniBA, Italy 0.04
Spanish National Center for Cardiovascular Research (CNIC), Spain 0.04
Institute of Physiology, CAS, Czech Republic 0.04
Biological Resource Centre (BRC), A*STAR, Singapore 0.02
Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore 0.02
Bristol Heart Institute (BHI), United Kingdom (UK) 0.02
Academic Department of Medical Genetics, University of Cambridge, United Kingdom (UK) 0.01
Alan Turing Institute, United Kingdom (UK) 0.01
MRC Biostatistics Unit (BSU), University of Cambridge, United Kingdom (UK) 0.01
Cardiovascular and Metabolic Disease, MDC, Germany 0.01
DZHK Partner Site Berlin, Germany 0.01
Charité - University Medicine Berlin, Germany 0.01
Berlin Institute of Health (BIH), Germany 0.01